96 related articles for article (PubMed ID: 9379310)
1. Synergism of cimetidine with anti-malarial agents.
Paciorkowski A; Dai WW; Cerami A; Berger BJ
J Parasitol; 1997 Oct; 83(5):960-3. PubMed ID: 9379310
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine.
Biswas S
Indian J Malariol; 2002; 39(1-2):26-33. PubMed ID: 14686107
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
Le Bras J
Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
[TBL] [Abstract][Full Text] [Related]
5. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
Djaman J; Abouanou S; Basco L; Koné M
Sante; 2004; 14(4):205-9. PubMed ID: 15745869
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
7. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
Ang HH; Chan KL; Mak JW
J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
[TBL] [Abstract][Full Text] [Related]
9. Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.
Bray PG; Deed S; Fox E; Kalkanidis M; Mungthin M; Deady LW; Tilley L
Biochem Pharmacol; 2005 Oct; 70(8):1158-66. PubMed ID: 16139253
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F
Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for Plasmodium falciparum resistance to chloroquine and pyrimethamine in Indochina and the Western Pacific between 1984 and 1998.
Saito-Nakano Y; Tanabe K; Kamei K; Iwagami M; Komaki-Yasuda K; Kawazu S; Kano S; Ohmae H; Endo T
Am J Trop Med Hyg; 2008 Oct; 79(4):613-9. PubMed ID: 18840753
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children.
Nirmala ; Kumar A; Kapoor AK; Lal B; Dutta GP; Swaroop A
Exp Parasitol; 1999 Sep; 93(1):33-7. PubMed ID: 10464036
[TBL] [Abstract][Full Text] [Related]
14. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
15. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi Malaria to various drugs and their combinations.
Rahman NN
Med J Malaysia; 1997 Dec; 52(4):390-8. PubMed ID: 10968116
[TBL] [Abstract][Full Text] [Related]
17. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
Min TH; Khairul MF; Low JH; Che Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Exp Parasitol; 2007 Apr; 115(4):387-92. PubMed ID: 17118354
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
[TBL] [Abstract][Full Text] [Related]
20. Biochemical aspects of drug action and resistance in malaria parasites.
Yuthavong Y; Panijpan B; Ruenwongsa P; Sirawaraporn W
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):459-72. PubMed ID: 3913002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
